Thanks Lykiri. It is definitely interesting. I am not so comfortable with the UK's rules and figuring them out and feeling confident I know their entire framework for managing their regulatory process. So I keep my commentary to a minimum on the UK side, at least until I feel a bit more confident on commenting. It does look very encouraging and I know the company, at least from what I have read here and what they seem to be saying to people calling them, is very interested in the UK's framework. And obviously, the entire Sawston endeavor suggests a lot greater comfort in the UK. Plus UK media are not limited to not talking about this and have published a lot of great stories about DCVax, which seems to amusingly annoy one of our "favorite" "journalists" here in the US.
Market Data 
Markets 
AI
